Related Experiment Videos
The pathogenesis of osteoporosis
1University Department of Endocrinology, Aarhus Amtssygehus, Aarhus C, Denmark. EFE@aas.arhusamt.dk
Hormone Research
|January 1, 1997
Summary
Osteoporosis pathogenesis involves genetic, hormonal, and environmental factors influencing bone mass. Menopause accelerates bone loss due to estrogen decline, while aging further impacts bone balance.
Area of Science:
- Bone biology and metabolic disorders.
- Endocrinology and aging research.
Background:
- Osteoporosis is defined by consensus and WHO criteria.
- Its pathogenesis is multifactorial, involving genetic, hormonal, and environmental influences.
- Key factors include peak bone mass attainment, menopausal bone loss, and age-dependent bone loss.
Purpose of the Study:
- To provide consensus and WHO definitions of osteoporosis.
- To elucidate the pathogenesis of osteoporosis, detailing influencing factors.
- To discuss proposed mechanisms and cellular roles in bone remodeling.
Main Methods:
- Review of consensus and WHO definitions.
- Analysis of factors affecting peak bone mass, menopausal bone loss, and age-dependent bone loss.
- Discussion of cellular mechanisms and hormonal influences on bone remodeling.
Main Results:
- Peak bone mass is primarily genetically determined but influenced by diet and exercise.
- Menopause leads to accelerated bone loss due to estrogen deficiency, shifting bone remodeling towards resorption.
- Aging further exacerbates bone loss due to osteoblast sensitivity and reduced calcium absorption.
Conclusions:
- Osteoporosis development is a complex interplay of genetics, hormones, and environment.
- Estrogen deficiency during menopause and aging significantly contribute to bone loss.
- Hormone replacement therapy can counteract menopausal bone loss trends.